Epacria Capital Partners’s Frontline FRO Stock Holding History

Epacria Capital Partners’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,621	Closed	-$301K	–	28
2026 Q1	$301K	Buy	+8,621	New	+$263K	0.23%	24
2023 Q4	–	Sell	-18,742	Closed	-$352K	–	57
2023 Q3	$352K	Hold	18,742	–	–	0.29%	49
2023 Q2	$272K	Sell	18,742 -2,817	-13%	-$42.1K	0.22%	52
2023 Q1	$357K	Buy	+21,559	New	+$339K	0.28%	50

Other funds holding FRO

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Keystone Investors Singapore $1.87B AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Epacria Capital Partners's FRO Position: Q2 2026 in Review

Epacria Capital Partners sold out of Frontline (FRO) in Q2 2026, closing a stake of 8,621 shares — an estimated $301K sold.

Epacria Capital Partners first reported a position in FRO in Q1 2023 and held it in 4 quarters. The position peaked at $357K in Q1 2023. 261 funds tracked by Wall St. Rank hold FRO as of Q2 2026.

Epacria Capital Partners reported no remaining Frontline position as of Q2 2026 after selling out during the quarter.
Epacria Capital Partners sold 8,621 Frontline shares in Q2 2026, an estimated $301K.
Epacria Capital Partners first reported a position in Frontline in Q1 2023 and held it in 4 quarters.
Epacria Capital Partners's Frontline position peaked at $357K in Q1 2023.
261 funds tracked by Wall St. Rank held Frontline as of Q2 2026.

Based on Epacria Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.